Aurora Cannabis (ACB) EBITDA Margin: 2018-2025
Historic EBITDA Margin for Aurora Cannabis (ACB) over the last 7 years, with Sep 2025 value amounting to 4.07%.
- Aurora Cannabis' EBITDA Margin rose 676.00% to 4.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.74%, marking a year-over-year increase of 1151.00%. This contributed to the annual value of 1.44% for FY2025, which is 1817.00% up from last year.
- As of Q3 2025, Aurora Cannabis' EBITDA Margin stood at 4.07%, which was up 382.58% from -1.44% recorded in Q2 2025.
- In the past 5 years, Aurora Cannabis' EBITDA Margin ranged from a high of 38.40% in Q4 2024 and a low of -29,174.69% during Q1 2021.
- For the 3-year period, Aurora Cannabis' EBITDA Margin averaged around -4.36%, with its median value being -3.82% (2024).
- As far as peak fluctuations go, Aurora Cannabis' EBITDA Margin slumped by 1,446,611bps in 2021, and later spiked by 1,017,805bps in 2022.
- Aurora Cannabis' EBITDA Margin (Quarterly) stood at -10,274.95% in 2021, then soared by 1,017,805bps to -96.90% in 2022, then spiked by 7,265bps to -24.25% in 2023, then soared by 6,265bps to 38.40% in 2024, then skyrocketed by 676bps to 4.07% in 2025.
- Its EBITDA Margin was 4.07% in Q3 2025, compared to -1.44% in Q2 2025 and -18.50% in Q1 2025.